Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 8857 to 8867 of 8867 entries
Sorted by: Best Match Show Resources per page
TXI (Texture and Color Enhancement Imaging) for Serrated Colorectal Lesions.

Journal of clinical medicine

Nishizawa T, Toyoshima O, Yoshida S, Uekura C, Kurokawa K, Munkhjargal M, Obata M, Yamada T, Fujishiro M, Ebinuma H, Suzuki H.
PMID: 35011860
J Clin Med. 2021 Dec 27;11(1). doi: 10.3390/jcm11010119.

BACKGROUND AND AIM: Olympus Corporation released the texture and color enhancement imaging (TXI) technology as a novel image-enhancing endoscopic technique. We investigated the effectiveness of TXI in the imaging of serrated colorectal polyps, including sessile serrated lesions (SSLs).METHODS: Serrated...

Cite
Nishizawa T, Toyoshima O, Yoshida S, et al. TXI (Texture and Color Enhancement Imaging) for Serrated Colorectal Lesions. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010119.
Nishizawa, T., Toyoshima, O., Yoshida, S., Uekura, C., Kurokawa, K., Munkhjargal, M., Obata, M., Yamada, T., Fujishiro, M., Ebinuma, H., & Suzuki, H. (2021). TXI (Texture and Color Enhancement Imaging) for Serrated Colorectal Lesions. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010119
Nishizawa, Toshihiro, et al. "TXI (Texture and Color Enhancement Imaging) for Serrated Colorectal Lesions." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010119
Nishizawa T, Toyoshima O, Yoshida S, Uekura C, Kurokawa K, Munkhjargal M, Obata M, Yamada T, Fujishiro M, Ebinuma H, Suzuki H. TXI (Texture and Color Enhancement Imaging) for Serrated Colorectal Lesions. J Clin Med. 2021 Dec 27;11(1). doi: 10.3390/jcm11010119. PMID: 35011860; PMCID: PMC8745100.
Copy Download .nbib Format: NLM
[No title available]

Journal of applied crystallography

Yamada T.
PMID: 34429725
J Appl Crystallogr. 2021 Jul 16;54:1252-1255. doi: 10.1107/S1600576721005951. eCollection 2021 Aug 01.

The atomic structure of quasicrystals (QCs) is described as a section of a higher-dimensional structure that consists of a periodic arrangement of occupation domains (ODs). Determination of the shape of ODs and their partitioning is crucial in the structural...

Cite
Yamada T. . J Appl Crystallogr. 2021;54:1252-1255doi: 10.1107/S1600576721005951.
Yamada, T. (2021). . Journal of applied crystallography, 541252-1255. https://doi.org/10.1107/S1600576721005951
Yamada, Tsunetomo. "." Journal of applied crystallography vol. 54 (2021): 1252-1255. doi: https://doi.org/10.1107/S1600576721005951
Yamada T. . J Appl Crystallogr. 2021 Jul 16;54:1252-1255. doi: 10.1107/S1600576721005951. eCollection 2021 Aug 01. PMID: 34429725; PMCID: PMC8366420.
Copy Download .nbib Format: NLM
Critical respiratory failure in pregnancy complicated with COVID-19: A case report.

Case reports in women's health

Chinen Y, Kinjyo Y, Mekaru K, Kinjo T, Higure Y, Kinjo T, Miyagi K, Yamada H, Masamoto H, Goya H, Yoshida T, Maeshiro S, Nakamatsu M, Fujita J, Aoki Y.
PMID: 33777708
Case Rep Womens Health. 2021 Apr;30:e00309. doi: 10.1016/j.crwh.2021.e00309. Epub 2021 Mar 23.

The case is presented of a 29-year-old primiparous woman who was COVID-19-positive at 34 weeks of gestation and who developed severe acute respiratory distress syndrome. After a four-day history of fever and mild dyspnea, she was referred to hospital....

Cite
Chinen Y, Kinjyo Y, Mekaru K, et al. Critical respiratory failure in pregnancy complicated with COVID-19: A case report. Case Rep Womens Health. 2021;30:e00309doi: 10.1016/j.crwh.2021.e00309.
Chinen, Y., Kinjyo, Y., Mekaru, K., Kinjo, T., Higure, Y., Kinjo, T., Miyagi, K., Yamada, H., Masamoto, H., Goya, H., Yoshida, T., Maeshiro, S., Nakamatsu, M., Fujita, J., & Aoki, Y. (2021). Critical respiratory failure in pregnancy complicated with COVID-19: A case report. Case reports in women's health, 30e00309. https://doi.org/10.1016/j.crwh.2021.e00309
Chinen, Yukiko, et al. "Critical respiratory failure in pregnancy complicated with COVID-19: A case report." Case reports in women's health vol. 30 (2021): e00309. doi: https://doi.org/10.1016/j.crwh.2021.e00309
Chinen Y, Kinjyo Y, Mekaru K, Kinjo T, Higure Y, Kinjo T, Miyagi K, Yamada H, Masamoto H, Goya H, Yoshida T, Maeshiro S, Nakamatsu M, Fujita J, Aoki Y. Critical respiratory failure in pregnancy complicated with COVID-19: A case report. Case Rep Womens Health. 2021 Apr;30:e00309. doi: 10.1016/j.crwh.2021.e00309. Epub 2021 Mar 23. PMID: 33777708; PMCID: PMC7986466.
Copy Download .nbib Format: NLM
Photodynamic therapy for pulmonary mucoepidermoid carcinoma.

Respiratory medicine case reports

Kimura M, Miyajima K, Ishikawa R, Yamada Y, Kono T, Okunaka T, Iwaya K, Ikeda N.
PMID: 34401275
Respir Med Case Rep. 2021 May 15;33:101431. doi: 10.1016/j.rmcr.2021.101431. eCollection 2021.

Pulmonary mucoepidermoid carcinoma (PMEC) are rare, accounting for 0.1-0.2% of all malignant lung tumors. Furthermore, endobronchial lesions are rare and are more commonly found in the segmental or lobar bronchi. We present, to the best of our knowledge, the...

Cite
Kimura M, Miyajima K, Ishikawa R, et al. Photodynamic therapy for pulmonary mucoepidermoid carcinoma. Respir Med Case Rep. 2021;33:101431doi: 10.1016/j.rmcr.2021.101431.
Kimura, M., Miyajima, K., Ishikawa, R., Yamada, Y., Kono, T., Okunaka, T., Iwaya, K., & Ikeda, N. (2021). Photodynamic therapy for pulmonary mucoepidermoid carcinoma. Respiratory medicine case reports, 33101431. https://doi.org/10.1016/j.rmcr.2021.101431
Kimura, Masakazu, et al. "Photodynamic therapy for pulmonary mucoepidermoid carcinoma." Respiratory medicine case reports vol. 33 (2021): 101431. doi: https://doi.org/10.1016/j.rmcr.2021.101431
Kimura M, Miyajima K, Ishikawa R, Yamada Y, Kono T, Okunaka T, Iwaya K, Ikeda N. Photodynamic therapy for pulmonary mucoepidermoid carcinoma. Respir Med Case Rep. 2021 May 15;33:101431. doi: 10.1016/j.rmcr.2021.101431. eCollection 2021. PMID: 34401275; PMCID: PMC8348553.
Copy Download .nbib Format: NLM
A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients.

Contemporary clinical trials communications

Yamada M, Miller DM, Lowe M, Rowe C, Wood D, Soyer HP, Byrnes-Blake K, Parrish-Novak J, Ishak L, Olson JM, Brandt G, Griffin P, Spelman L, Prow TW.
PMID: 34401600
Contemp Clin Trials Commun. 2021 Aug 04;23:100830. doi: 10.1016/j.conctc.2021.100830. eCollection 2021 Sep.

BLZ-100 (tozuleristide) is an intraoperative fluorescent imaging agent that selectively detects malignant tissue and can be used in real time to guide tumor resection. The purpose of this study was to assess the safety, tolerability, and pharmacokinetics of BLZ-100...

Cite
Yamada M, Miller DM, Lowe M, et al. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp Clin Trials Commun. 2021;23:100830doi: 10.1016/j.conctc.2021.100830.
Yamada, M., Miller, D. M., Lowe, M., Rowe, C., Wood, D., Soyer, H. P., Byrnes-Blake, K., Parrish-Novak, J., Ishak, L., Olson, J. M., Brandt, G., Griffin, P., Spelman, L., & Prow, T. W. (2021). A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemporary clinical trials communications, 23100830. https://doi.org/10.1016/j.conctc.2021.100830
Yamada, Miko, et al. "A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients." Contemporary clinical trials communications vol. 23 (2021): 100830. doi: https://doi.org/10.1016/j.conctc.2021.100830
Yamada M, Miller DM, Lowe M, Rowe C, Wood D, Soyer HP, Byrnes-Blake K, Parrish-Novak J, Ishak L, Olson JM, Brandt G, Griffin P, Spelman L, Prow TW. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients. Contemp Clin Trials Commun. 2021 Aug 04;23:100830. doi: 10.1016/j.conctc.2021.100830. eCollection 2021 Sep. PMID: 34401600; PMCID: PMC8355837.
Copy Download .nbib Format: NLM
Direct platelet adhesion potentiates group 2 innate lymphoid cell functions.

Allergy

Orimo K, Tamari M, Takeda T, Kubo T, Rückert B, Motomura K, Sugiyama H, Yamada A, Saito K, Arae K, Kuriyama M, Hara M, Soyka MB, Ikutani M, Yamaguchi S, Morimoto N, Nakabayashi K, Hata K, Matsuda A, Akdis CA, Sudo K, Saito H, Nakae S, Tamaoki J, Tagaya E, Matsumoto K, Morita H.
PMID: 34402091
Allergy. 2021 Aug 17; doi: 10.1111/all.15057. Epub 2021 Aug 17.

BACKGROUND: Platelets are thought to be involved in the pathophysiology of asthma, presumably through direct adhesion to inflammatory cells, including group 2 innate lymphoid cells (ILC2s). Here, we tried to elucidate the effects of platelet adhesion to ILC2s in...

Cite
Orimo K, Tamari M, Takeda T, et al. Direct platelet adhesion potentiates group 2 innate lymphoid cell functions. Allergy. 2021;doi: 10.1111/all.15057.
Orimo, K., Tamari, M., Takeda, T., Kubo, T., Rückert, B., Motomura, K., Sugiyama, H., Yamada, A., Saito, K., Arae, K., Kuriyama, M., Hara, M., Soyka, M. B., Ikutani, M., Yamaguchi, S., Morimoto, N., Nakabayashi, K., Hata, K., Matsuda, A., Akdis, C. A., Sudo, K., Saito, H., Nakae, S., Tamaoki, J., Tagaya, E., Matsumoto, K., & Morita, H. (2021). Direct platelet adhesion potentiates group 2 innate lymphoid cell functions. Allergy, . https://doi.org/10.1111/all.15057
Orimo, Keisuke, et al. "Direct platelet adhesion potentiates group 2 innate lymphoid cell functions." Allergy vol. (2021). doi: https://doi.org/10.1111/all.15057
Orimo K, Tamari M, Takeda T, Kubo T, Rückert B, Motomura K, Sugiyama H, Yamada A, Saito K, Arae K, Kuriyama M, Hara M, Soyka MB, Ikutani M, Yamaguchi S, Morimoto N, Nakabayashi K, Hata K, Matsuda A, Akdis CA, Sudo K, Saito H, Nakae S, Tamaoki J, Tagaya E, Matsumoto K, Morita H. Direct platelet adhesion potentiates group 2 innate lymphoid cell functions. Allergy. 2021 Aug 17; doi: 10.1111/all.15057. Epub 2021 Aug 17. PMID: 34402091.
Copy Download .nbib Format: NLM
Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study.

Pneumonia (Nathan Qld.)

Suzuki J, Sasabuchi Y, Hatakeyama S, Matsui H, Sasahara T, Morisawa Y, Yamada T, Fushimi K, Yasunaga H.
PMID: 35012674
Pneumonia (Nathan). 2022 Jan 10;14(1):1. doi: 10.1186/s41479-021-00093-8.

BACKGROUND: Community-acquired pneumonia (CAP) is the most common cause of acute respiratory distress syndrome (ARDS). Although previous studies have suggested that macrolide therapy is beneficial for ARDS, its benefit for severe CAP-associated ARDS remains uncertain. Previous studies were limited...

Cite
Suzuki J, Sasabuchi Y, Hatakeyama S, et al. Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study. Pneumonia (Nathan). 2022;14(1):1doi: 10.1186/s41479-021-00093-8.
Suzuki, J., Sasabuchi, Y., Hatakeyama, S., Matsui, H., Sasahara, T., Morisawa, Y., Yamada, T., Fushimi, K., & Yasunaga, H. (2022). Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study. Pneumonia (Nathan Qld.), 14(1), 1. https://doi.org/10.1186/s41479-021-00093-8
Suzuki, Jun, et al. "Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study." Pneumonia (Nathan Qld.) vol. 14,1 (2022): 1. doi: https://doi.org/10.1186/s41479-021-00093-8
Suzuki J, Sasabuchi Y, Hatakeyama S, Matsui H, Sasahara T, Morisawa Y, Yamada T, Fushimi K, Yasunaga H. Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort study. Pneumonia (Nathan). 2022 Jan 10;14(1):1. doi: 10.1186/s41479-021-00093-8. PMID: 35012674; PMCID: PMC8744237.
Copy Download .nbib Format: NLM
A new severity classification of lower limb secondary lymphedema based on lymphatic pathway defects in an indocyanine green fluorescent lymphography study.

Scientific reports

Shinaoka A, Kamiyama K, Yamada K, Kimata Y.
PMID: 35013357
Sci Rep. 2022 Jan 10;12(1):309. doi: 10.1038/s41598-021-03637-6.

Most protocols for lymphatic imaging of the lower limb conventionally inject tracer materials only into the interdigital space; however, recent studies indicate that there are four independent lymphatic vessel groups (anteromedial, anterolateral, posteromedial, and posterolateral) in the lower limb....

Cite
Shinaoka A, Kamiyama K, Yamada K, et al. A new severity classification of lower limb secondary lymphedema based on lymphatic pathway defects in an indocyanine green fluorescent lymphography study. Sci Rep. 2022;12(1):309doi: 10.1038/s41598-021-03637-6.
Shinaoka, A., Kamiyama, K., Yamada, K., & Kimata, Y. (2022). A new severity classification of lower limb secondary lymphedema based on lymphatic pathway defects in an indocyanine green fluorescent lymphography study. Scientific reports, 12(1), 309. https://doi.org/10.1038/s41598-021-03637-6
Shinaoka, Akira, et al. "A new severity classification of lower limb secondary lymphedema based on lymphatic pathway defects in an indocyanine green fluorescent lymphography study." Scientific reports vol. 12,1 (2022): 309. doi: https://doi.org/10.1038/s41598-021-03637-6
Shinaoka A, Kamiyama K, Yamada K, Kimata Y. A new severity classification of lower limb secondary lymphedema based on lymphatic pathway defects in an indocyanine green fluorescent lymphography study. Sci Rep. 2022 Jan 10;12(1):309. doi: 10.1038/s41598-021-03637-6. PMID: 35013357; PMCID: PMC8748503.
Copy Download .nbib Format: NLM
Establishment of large canine hepatocyte spheroids by mixing vascular endothelial cells and canine adipose-derived mesenchymal stem cells.

Regenerative therapy

Ichikawa A, Neo S, Nukui R, Yamada Y, Nitta S, Iwaki H, Yanagi Y, Nakayama K, Sato S, Tateishi S, Hisasue M.
PMID: 35024388
Regen Ther. 2021 Dec 29;19:1-8. doi: 10.1016/j.reth.2021.11.007. eCollection 2022 Mar.

INTRODUCTION: Differentiation of hepatocytes and culture methods have been investigated in dogs as a tool to establish liver transplant and drug metabolism examination systems. However, mass culture techniques for canine hepatocytes (cHep) have not been investigated, and it is...

Cite
Ichikawa A, Neo S, Nukui R, et al. Establishment of large canine hepatocyte spheroids by mixing vascular endothelial cells and canine adipose-derived mesenchymal stem cells. Regen Ther. 2021;19:1-8doi: 10.1016/j.reth.2021.11.007.
Ichikawa, A., Neo, S., Nukui, R., Yamada, Y., Nitta, S., Iwaki, H., Yanagi, Y., Nakayama, K., Sato, S., Tateishi, S., & Hisasue, M. (2022). Establishment of large canine hepatocyte spheroids by mixing vascular endothelial cells and canine adipose-derived mesenchymal stem cells. Regenerative therapy, 191-8. https://doi.org/10.1016/j.reth.2021.11.007
Ichikawa, Akito, et al. "Establishment of large canine hepatocyte spheroids by mixing vascular endothelial cells and canine adipose-derived mesenchymal stem cells." Regenerative therapy vol. 19 (2022): 1-8. doi: https://doi.org/10.1016/j.reth.2021.11.007
Ichikawa A, Neo S, Nukui R, Yamada Y, Nitta S, Iwaki H, Yanagi Y, Nakayama K, Sato S, Tateishi S, Hisasue M. Establishment of large canine hepatocyte spheroids by mixing vascular endothelial cells and canine adipose-derived mesenchymal stem cells. Regen Ther. 2021 Dec 29;19:1-8. doi: 10.1016/j.reth.2021.11.007. eCollection 2022 Mar. PMID: 35024388; PMCID: PMC8728312.
Copy Download .nbib Format: NLM
Early concerns in parents of infants at risk for autism.

Developmental medicine and child neurology

Tran AT, Del Rosario M, Nosco E, Li Y, Senturk D, Mcdonald NM, Wilson RB, Dapretto M, Jeste SS.
PMID: 34109620
Dev Med Child Neurol. 2021 Dec;63(12):1410-1416. doi: 10.1111/dmcn.14925. Epub 2021 Jun 09.

AIM: To examine parental concerns about children at increased familial risk (i.e. high risk) of developing autism spectrum disorder (ASD) in early infancy.METHOD: ASD-related and general parental concerns were prospectively collected for 76 infants at ages 1.5, 3, 6,...

Cite
Tran AT, Del Rosario M, Nosco E, et al. Early concerns in parents of infants at risk for autism. Dev Med Child Neurol. 2021;63(12):1410-1416doi: 10.1111/dmcn.14925.
Tran, A. T., Del Rosario, M., Nosco, E., Li, Y., Senturk, D., Mcdonald, N. M., Wilson, R. B., Dapretto, M., & Jeste, S. S. (2021). Early concerns in parents of infants at risk for autism. Developmental medicine and child neurology, 63(12), 1410-1416. https://doi.org/10.1111/dmcn.14925
Tran, Amanda T, et al. "Early concerns in parents of infants at risk for autism." Developmental medicine and child neurology vol. 63,12 (2021): 1410-1416. doi: https://doi.org/10.1111/dmcn.14925
Tran AT, Del Rosario M, Nosco E, Li Y, Senturk D, Mcdonald NM, Wilson RB, Dapretto M, Jeste SS. Early concerns in parents of infants at risk for autism. Dev Med Child Neurol. 2021 Dec;63(12):1410-1416. doi: 10.1111/dmcn.14925. Epub 2021 Jun 09. PMID: 34109620; PMCID: PMC8666093.
Copy Download .nbib Format: NLM
OSCE-based Clinical Skill Education for Physical and Occupational Therapists.

Sakurai H, Kanada Y, Sugiura Y, Motoya I, Wada Y, Yamada M, Tomita M, Tanabe S, Teranishi T, Tsujimura T, Sawa S, Okanishi T.
UIID-AD: 2870
2014;26:1387-97. doi: 10.1589/jpts.26.1387.

[Purpose] The aim of this study was to examine the applicability of the Objective Structured Clinical Examination (OSCE) to postgraduate education systems for novice and mid-career therapists in workplaces. [Subjects] Physical and occupational therapists with 1 to 5 years...

Cite
Sakurai H, Kanada Y, Sugiura Y, et al. OSCE-based Clinical Skill Education for Physical and Occupational Therapists. 2014;26:1387-97doi: 10.1589/jpts.26.1387.
Sakurai, H., Kanada, Y., Sugiura, Y., Motoya, I., Wada, Y., Yamada, M., Tomita, M., Tanabe, S., Teranishi, T., Tsujimura, T., Sawa, S., & Okanishi, T. (2014). OSCE-based Clinical Skill Education for Physical and Occupational Therapists. 261387-97. https://doi.org/10.1589/jpts.26.1387
Sakurai, H, et al. "OSCE-based Clinical Skill Education for Physical and Occupational Therapists." vol. 26 (2014): 1387-97. doi: https://doi.org/10.1589/jpts.26.1387
Sakurai H, Kanada Y, Sugiura Y, Motoya I, Wada Y, Yamada M, Tomita M, Tanabe S, Teranishi T, Tsujimura T, Sawa S, Okanishi T. OSCE-based Clinical Skill Education for Physical and Occupational Therapists. 2014;26:1387-97. doi: 10.1589/jpts.26.1387. UIID-AD: 2870.
Copy Download .nbib Format: NLM
Showing 8857 to 8867 of 8867 entries